Literature DB >> 146479

Allopurinol associated hypersensitivity reactions: cutaneous and renal manifestations.

H L Chan, G Ku, O T Khoo.   

Abstract

Five patients developed fever, "toxaemia", severe skin reactions and eosinophilia, three to six weeks after commencing allopurinol therapy. The presenting feature in these patients was an extensive erythema, progressing to an exfoliative dermatitis, sometimes with oral mucous membrane involvement. One patient developed toxic epidermal necrolysis. The clinical course in two patients was complicated by acute renal failure which necessitated dialysis. The clinical and laboratory features support an acute hypersensitivity mechanism in these allopurinol associated reactions, in agreement with previous studies. Patients with chronic renal failure appear particularly prone to severe, potentially fatal reactions. If these patients need allopurinol, a lower dose than would be normally required should be given.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 146479     DOI: 10.1111/j.1445-5994.1977.tb03375.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  5 in total

1.  Hypersensitivity reactions to deoxycoformycin.

Authors:  P J O'Dwyer; S A King; E Eisenhauer; J L Grem; D F Hoth
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Granulomatous interstitial nephritis associated with allopurinol therapy.

Authors:  P Magner; J Sweet; R A Bear
Journal:  CMAJ       Date:  1986-09-01       Impact factor: 8.262

3.  Allopurinol, erythema multiforme, and renal insufficiency.

Authors:  A Kumar; N Edward; M I White; P W Johnston; G R Catto
Journal:  BMJ       Date:  1996-01-20

4.  Severe cutaneous reactions requiring hospitalization in allopurinol initiators: a population-based cohort study.

Authors:  Seoyoung C Kim; Craig Newcomb; David Margolis; Jason Roy; Sean Hennessy
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

Review 5.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.